Skip to main content
SpringerLink
Log in

Reduction of NICE cost-effectiveness threshold recommended

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. O'Dowd A.Economist says NICE should approve fewer costly drugs. BMJ 335: 11, No. 7609, 7 Jul 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reduction of NICE cost-effectiveness threshold recommended. Pharmacoecon. Outcomes News 532, 2 (2007). https://doi.org/10.2165/00151234-200705320-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705320-00002

Keywords

Search

Navigation